Professor Roy Taylor joins Lauren Southwell to talk about his Review discussing the causes of type 2 diabetes.Door The Lancet

Professor Ponnusamy Saravanan, Dr Uma Ram, and Dr Kosgei Wycliffe join Lauren Southwell to discuss STRiDE, a prospective cohort study in India and Kenya, and the multi-ethnic PRiDE cohort in the UK to assess early pregnancy HbA1c as a screening test for gestational diabetes.Door The Lancet

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.Door The Lancet

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective.Door The Lancet

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.Door The Lancet

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health.Door The Lancet

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches.Door The Lancet

Margherita Pizzato talks with The Lancet Diabetes & Endocrinology about the global epidemiological landscape of thyroid cancer based on GLOBOCAN estimates in 2020.Door The Lancet

Angela Titmuss talks with The Lancet Diabetes & Endocrinology about youth-onset type 2 diabetes among First Nations young people in northern Australia.Door The Lancet

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.Door The Lancet

Philip Home talks with The Lancet Diabetes & Endocrinology about the insulin centenary and how insulin therapy might develop in the future.Door The Lancet

Victoria Salem talks with The Lancet Diabetes & Endocrinology about how to improve female inclusion and participation in scientific medical conferences.Door The Lancet

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.Door The Lancet

Rishi Caleyachetty talks with The Lancet Diabetes & Endocrinology about the need to revise ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk.Door The Lancet

Thomas Robinson talks with The Lancet Diabetes & Endocrinology about the Stanford GOALS randomised controlled trial in Latinx children with overweight or obesity.Door The Lancet

Adrian Martineau talks with The Lancet Diabetes & Endocrinology about how vitamin D supplementation can reduce the risk of acute respiratory infections.Door The Lancet

William Kraus talks with The Lancet Diabetes & Endocrinology about how calorie restriction can reduce cardiometabolic risk even in young, healthy, non-obese adults.Door The Lancet

Hiddo Lambers Heerspink talks with The Lancet Diabetes & Endocrinology about his work on changes in albuminuria and subsequent effect on kidney disease.Door The Lancet

Mark Atkinson and Bart Roep join The Lancet Diabetes & Endocrinology to discuss a new Series on immune-based therapies for type 1 diabetes.Door The Lancet

Series authors Annewieke van den Beld, Bu Yeap, Robin Peeters, and Zaki Hassan-Smith discuss how the endocrine system changes with age and the implications for healthy ageing.Door The Lancet

Mohammed Ali talks to The Lancet Diabetes & Endocrinology about the cardiovascular and renal burdens of prediabetes in the USA.Door The Lancet

Richard Oram discusses a study which uses UK Biobank data to look at the frequency of type 1 diabetes across the first six decades of life.Door The Lancet

Michael Zimmerman talks about the effect of iodine supplementation in pregnant women on child development.Door The Lancet

Moffat Nyirenda talks about the challenges facing diabetes in sub-Saharan Africa, as highlighted in a new Commission.Door The Lancet

Martin Reincke discusses outcomes after adrenalectomy for unilateral primary aldosteronism.Door The Lancet

Two authors of papers on bariatric surgery in adolescents, Thomas Inge and Torsten Olbers, discuss their work, published in The Lancet Diabetes and Endocrinology.Door The Lancet

Professor Mark Hanson, Director of the Institute of Developmental Sciences at the University of Southampton, discusses the society and policy changes needed to tackle the growing epidemic of maternal obesity worldwide.Door The Lancet

Professor Paul Little talks about the PoWER+ trial, a system aimed at cost-effective, internet-based support for weight loss.Door The Lancet

Dr Francesco Zaccardi discusses an article about hospital admissions for hypoglycaemia in England from 2005 to 2015.Door The Lancet

Dr. Justin White discusses neighbourhood effects and how to research themDoor The Lancet

Ellen Flint and Caroline Brogan discuss the effect of active commuting on BMI and obesity.Door The Lancet

David Beran discusses the challenges faced around the world to accessing insulin.Door The Lancet

Barry Popkin discusses how public health measures globally need to address sugar content in beverages and food.Door The Lancet

Lucilla Poston discusses results of the UPBEAT trial, which tested whether an intensive lifestyle intervention in obese women during pregnancy can reduce the incidence of gestational diabetes and large-for-gestational-age babies.Door The Lancet

How do different methods for diagnosing diabetes affect estimates of prevalence and how is this likely to affect global estimates of this disease?Door The Lancet

Does smoking cessation affect glycaemic control in people with diabetes?Door The Lancet

Alexandra Papaioannou and John Schousboe discuss the pros and cons of expanding diagnostic criteria for osteoporosis.Door The Lancet

Dick de Zeeuw discusses a trial looking at the effect of statins on renal function.Door The Lancet

Lawrence Phillips talks about a study looking at the effects of a lifestyle programme on diabetes incidence and weight loss in a real-world population in the USA.Door The Lancet

Edward Gregg from the US Centers for Disease Control discusses the rise in US diabetes incidence, and a concurrent fall in mortality from diabetes.Door The Lancet

John Deanfield discusses lifetime changes in BMI and cardiovascular risk.Door The Lancet

John Wentworth and Paul O'Brien discuss a randomized trial of bariatric surgery for overweight, non-obese people with type 2 diabetes.Door The Lancet

Dr Rowan Gillies joins Natalie Harrison to discuss surgery for people with diabetes in low-income and middle-income countries.Door The Lancet

Norbert Stefan discusses a small but positive trial of a new drug in people with non-alcoholic fatty liver disease.Door The Lancet

Mark Bolland discusses the results of a sequential trial meta-analysis of the effects of vitamin D supplementation on skeletal, vascular, and cancer outcomes.Door The Lancet

Michael Nauck discusses incretin-based drugs and pancreatitis risk.Door The Lancet

Ambady Ramachandran discusses using text messaging to prevent diabetes in men at high risk of developing the disease.Door The Lancet

Rachel Whitmer discusses a dementia risk score for people with type 2 diabetes.Door The Lancet

Anna Peeters discusses diabetes and risk of physical disability in adults.Door The Lancet

Deputy Editor Sarah Allan discusses the contents of a special preview of The Lancet Diabetes & Endocrinology, as well as plans for the journal's launch in September.Door The Lancet